GlassScriptPhysician profile
Kirsten Grau
NPI 1538398706
$955.15
in general payments reported to CMS, 2019-2025
13 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.60 · 2020: $57.62 · 2021: $39.36 · 2022: $116 · 2023: $238 · 2024: $151 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $258.38 | 2020-2024 | Grafix Pl, Collagenase Santyl, Regranex |
| Trilliant Surgical LLC. | $150.00 | 2025 | Arsenal Ankle |
| Amgen INC. | $132.23 | 2025 | Krystexxa |
| Treace Medical Concepts, INC. | $122.08 | 2023-2025 | |
| Organogenesis INC. | $74.66 | 2023 | Puraply |
| Stryker Corporation | $45.64 | 2024 | Phalinx, Ortholoc 3di Crosscheck, Easyfuse |
| Dynasplint Systems INC. | $41.05 | 2023 | Dynasplint |
| Grt US Holding, INC. | $28.77 | 2020-2021 | |
| Melinta Therapeutics, LLC | $23.60 | 2019 | |
| Advanced Oxygen Therapy INC. | $23.55 | 2021 | |
| Averitas Pharma INC. | $22.40 | 2024 | Qutenza |
| Paratek Pharmaceuticals, INC. | $17.32 | 2025 | Nuzyra |
| Bioventus LLC | $15.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirsten Grau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.